Publications by authors named "Carlo Pozzilli"

Claim this Profile
R
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty.
Gina Ferrazzano, Roberta Fantozzi, Shalom Haggiag, Doriana Landi, Francesca Napoli, Valeria Pozzilli, Carlo Pozzilli

Neurol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments.
Ermelinda De Meo, Ilaria Addazio, Emilio Portaccio, Raffaello Bonacchi, Matteo Betti, Carlo Pozzilli

Neurology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study.
Matteo Lucchini, Giovanna Borriello, Shalom Haggiag, Carolina Gabri Nicoletti, Roberta Fantozzi, Carlo Pozzilli

Ther Adv Neurol Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional connectivity changes are associated with disability progression in multiple sclerosis: a longitudinal fMRI study.
Claudia Piervincenzi, Abhineet Ojha, Silvia Tommasin, Federica Satriano, Nikolaos Petsas, Carlo Pozzilli

J Neurol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing autoimmune comorbidities in multiple sclerosis: A case report of ulcerative colitis remission in a patient treated with cladribine tablets.
Elena Barbuti, Carlo Pozzilli, Giovanna Borriello, Maria Petracca

Mult Scler· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sclerosis from onset to secondary progression: a 30-year Italian register study.
Aurora Zanghì, Massimiliano Copetti, Carlo Avolio, Damiano Paolicelli, Marzia Anita Lucia Romeo, Carlo Pozzilli

J Neurol Neurosurg Psychiatry· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Intensive Versus Escalation Approach: Ten-Year Impact on Disability in Relapsing Multiple Sclerosis.
Pietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra, Francesca Caputo, Marta Simone, Carlo Pozzilli

Ann Clin Transl Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Ponesimod as add-on treatment in patients with active relapsing multiple sclerosis under dimethyl fumarate (POINT): A phase 3, randomized, placebo-controlled clinical trial.
Ludwig Kappos, Michel Burcklen, Daniele D'Ambrosio, Robert J Fox, Mark S Freedman, Carlo Pozzilli

Mult Scler Relat Disord· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis.
Emilio Portaccio, Matteo Betti, Ermelinda De Meo, Luisa Pastò, Elio Prestipino, Carlo Pozzilli

Neurology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How premorbid structural reserve affects disability accrual in multiple sclerosis.
Elena Barbuti, Luca Prosperini, Serena Ruggieri, Shalom Haggiag, Alessandro Stasolla, Carlo Pozzilli

Mult Scler· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis: Results of the Phase 3 OCARINA II Study.
Scott D Newsome, Ewa Krzystanek, Krzysztof W Selmaj, Michal Dufek, Lawrence Goldstick, Carlo Pozzilli

Neurology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensus.
Massimo Filippi, Maria Pia Amato, Diego Centonze, Paolo Gallo, Claudio Gasperini, Carlo Pozzilli

J Neurol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosis.
Emilio Portaccio, Matteo Betti, Ermelinda De Meo, Luisa Pastò, Lorenzo Razzolini, Carlo Pozzilli

Mult Scler· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis: Results of the Phase 3 OCARINA II Study.
Scott D Newsome, Ewa Krzystanek, Krzysztof W Selmaj, Michal Dufek, Lawrence Goldstick, Carlo Pozzilli

Neurology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of microglia in multiple sclerosis: implications for treatment with Bruton's tyrosine kinase inhibitors.
Patrick Vermersch, Laura Airas, Thomas Berger, Florian Deisenhammer, Nikolaos Grigoriadis, Carlo Pozzilli

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and MRI features contributing to the clinico-radiological dissociation in a large cohort of people with multiple sclerosis.
Abhineet Ojha, Silvia Tommasin, Claudia Piervincenzi, Viola Baione, Emma Gangemi, Carlo Pozzilli

J Neurol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generics, Biosimilars and Follow-On Non-Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists.
Thomas Berger, Markus Zeitlinger, Veronica Popescu, Melinda Magyari, Laura Airas, Carlo Pozzilli

Eur J Neurol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study.
Elena Barbuti, Alessia Castiello, Valeria Pozzilli, Antonio Carotenuto, Ilaria Tomasso, Carlo Pozzilli

Neurotherapeutics· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of measured and perceived disability in overweight patients with Multiple Sclerosis trough different patterns of Mediterranean hypocaloric diet.
Federica Felicetti, Serena Ruggieri, Ilaria Ruotolo, Chiara Livi, Giovanni Sellitto, Carlo Pozzilli

Mult Scler Relat Disord· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedules.
Giorgio Leodori, Marco Mancuso, Davide Maccarrone, Matteo Tartaglia, Antonio Ianniello, Carlo Pozzilli

Mult Scler Relat Disord· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod.
Antonio Carotenuto, Cristina Di Monaco, Laura Papetti, Giovanna Borriello, Elisabetta Signoriello, Carlo Pozzilli

J Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis.
Marta Simone, Giuseppe Lucisano, Tommaso Guerra, Damiano Paolicelli, Maria A Rocca, Carlo Pozzilli

J Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of Kinesio Taping® on manual dexterity in Multiple Sclerosis: A double-blind, parallel-arm, pilot study.
Letizia Castelli, Chiara Iacovelli, Claudia Loreti, Augusto Fusco, Carmela Riso, Carlo Pozzilli

J Bodyw Mov Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain reserve and timing of clinical onset in multiple sclerosis.
Maria Petracca, Serena Ruggieri, Riccardo Nistri, Ilaria Tomasso, Elena Barbuti, Valeria Pozzilli, Carlo Pozzilli

Mult Scler· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telerehabilitation and onsite rehabilitation effectively improve quality of life, fatigue, balance, and cognition in people with multiple sclerosis: an interventional study.
Maria Petracca, Nikolaos Petsas, Giovanni Sellitto, Ilaria Ruotolo, Chiara Livi, Carlo Pozzilli

Front Neurol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis